Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.660
-0.080-0.82%
Volume:70.90M
Turnover:684.38M
Market Cap:111.30B
PE:23.23
High:9.820
Open:9.530
Low:9.450
Close:9.740
52wk High:11.454
52wk Low:4.346
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.28
T/O Rate:0.62%
Dividend:0.24
Dividend Rate:2.48%
EPS(LYR):0.416
ROE:10.83%
ROA:5.65%
PB:2.97
PE(LYR):23.23
PS:3.77

Loading ...

Tirzepatide Crowned as New "Blockbuster Drug King" with Rapid Commercial Value Release Expected for Weight Loss Medications

Stock News
·
Feb 05

CSPC Pharmaceutical Group Stock Falls 2.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Feb 04

BUZZ-CSPC Pharmaceutical jumps most in eight months on hypertension drug approval

Reuters
·
Feb 03

HK Stock Movement | CSPC PHARMA (01093) Rises Nearly 6% as Institutions Expect BD Deals to Support Earnings and Dividends

Stock News
·
Feb 03

CSPC PHARMACEUTICAL GROUP LIMITED (01093) Issues Monthly Return for January 2026

Bulletin Express
·
Feb 02

BREAKINGVIEWS-Asian investment banking is at an inflection point

Reuters
·
Feb 02

CSPC Pharmaceutical Group Receives Approval for Clevidipine Injectable Emulsion

Reuters
·
Feb 02

CSPC PHARMA (01093) Receives Drug Registration Approval for Clevidipine Butyrate Lipid Emulsion Injection

Stock News
·
Feb 02

CSPC Pharmaceutical - Approval Granted by Nmpa.

THOMSON REUTERS
·
Feb 02

CSPC Pharmaceutical - Clevidipine Injectable Emulsion Approved in China

THOMSON REUTERS
·
Feb 02

CSPC Pharmaceutical Group Stock Slips 4.7% in Hong Kong

Dow Jones
·
Feb 02

Bank of America Securities Raises CSPC PHARMA (01093) Target Price to HK$9.1, Reiterates "Underperform" Rating

Stock News
·
Feb 02

BREAKINGVIEWS-AstraZeneca escalates Big Pharma’s China land grab

Reuters
·
Feb 02

CMSC International Reiterates "Neutral" Rating on CSPC PHARMA (01093) as Chinese Innovative Drugs Enter Global Pipeline

Stock News
·
Feb 02

CICC Maintains "Outperform" Rating on CSPC PHARMA (01093) Following Major AstraZeneca Collaboration

Stock News
·
Feb 02

Inking $18.5 Billion Mega-Deal, Why Did CSPC PHARMA Face Sell-Off? "Smart Money" Quietly Accumulates via HUABAO HANG SENG HONG KONG STOCK CONNECT INNOVATIVE DRUG SELECTION TRADING OPEN ENDED INDEX SECURITIES INVES (520880)

Deep News
·
Feb 01

$18.5 Billion! CSPC PHARMA's Record-Breaking BD Deal Finalized, Yet Stock Plunges 10%—What's Happening?

Deep News
·
Jan 30

Northbound Funds Record Net Purchase of HK$3.22 Billion; CSPC PHARMA (01093) Announces Major BD Deal, Attracts Over HK$900 Million Inflows

Stock News
·
Jan 30

CSPC Pharma Shares Drop on Possible Profit-Taking After AstraZeneca Deal

Dow Jones
·
Jan 30

AstraZeneca Pays Top Dollar for Early-Stage Obesity Drugs -- Market Talk

Dow Jones
·
Jan 30